학술논문
Neuromyelitis optica associated with the use of Atezolizumab in a patient with advanced lung adenocarcinoma
Document Type
Original Paper
Author
Source
Neurological Sciences. 45(5):2199-2202
Subject
Language
English
ISSN
1590-1874
1590-3478
1590-3478
Abstract
Immune checkpoint inhibitors (ICIs) are a pharmacological group increasingly used in Oncology and Hematology. These treatments can lead to autoimmune complications, with neurological conditions, especially central nervous system (CNS) involvement, being rare. We describe a case of seropositive neuromyelitis optica in a patient with locally advanced lung adenocarcinoma treated with Atezolizumab.